Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Mumbai-based Glenmark Pharmaceuticals has received FDA approval to market pravastatin sodium tablets 10mg, 20mg and 40mg, a generic version of Bristol-Myers Squibb's statin Pravachol.
Subscribe to our email newsletter
Pravachol, a cholesterol-lowering drug, has annual sales of over $861 million, according to Glenmark. The generics company said that it is manufacturing the formulation in its facility in Goa, India.
Last month, Glenmark also received US FDA approval to market naproxen sodium tablets, a generic version of Roche’s brand Anaprox and naproxen tablets, a generic version of Roche’s brand Naprosyn.